ArticleBMC gastroenterology2021

First report on molecular docking analysis and drug resistance substitutions to approved HCV NS5A and NS5B inhibitors amongst Iranian patients.

Zahra Hasanshahi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.